[PE21] Poster Session 21
Food allergy-Immunotherapy

[PE21-2] Safety of ultralow-dose of antigen oral immunotherapy in pediatric patients with severe peanut allergy: induction, fixed-dose, and escalation phases

Kyoko S Nishikage^1,2, Takeharu Yamanaka² (1.Yokohama Nishikage Clinic:kids and allergies, Japan, 2.Department of Biostatistics, School of Medicine, Yokohama City University, Japan)